SCHEMBL8764157

SCHEMBL8764157

COC(=O)CCN1CCN(Cc2ccccc2)C[C@H](NC(=O)OCc2ccccc2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CTSL P07711 1/20 0.43
▸ CTSB P07858 1/20 0.43
▸ CTSK P43235 1/20 0.43
▸ CASP3 P42574 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ BCHE P06276 2/20 0.41
▸ ACHE P22303 2/20 0.41
▸ CACNA1F O60840 1/20 0.41
▸ CACNA1D Q01668 1/20 0.41
▸ CACNA1S Q13698 1/20 0.41
▸ CACNA1C Q13936 1/20 0.41
▸ PREP P48147 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13547350 0.88 SMN1; SMN2 (0.47) SMN1; SMN2CTSLCTSBCTSKCASP3
SCHEMBL13875779 0.81 HDAC1 (0.47) SMN1; SMN2ALDH1A1LMNABCHEACHE
SCHEMBL949589 0.80 CTSK (0.43) SMN1; SMN2CTSLCTSBCTSKALDH1A1
SCHEMBL949590 0.80 CTSK (0.43) SMN1; SMN2CTSLCTSBCTSKALDH1A1
SCHEMBL12450523 0.76 CASP1 (0.47) SMN1; SMN2CTSLCTSBCTSKCASP3
SCHEMBL14610301 0.75 CASP3 (0.55) CTSLCTSBCTSKCASP3ALDH1A1
SCHEMBL13637760 0.75 CASP1 (0.55) CTSLCTSBCASP3
SCHEMBL8641646 0.74 CTSL (0.46) CTSLCTSBCTSKCASP3ALDH1A1
SCHEMBL8641654 0.74 CTSL (0.46) CTSLCTSBCTSKCASP3ALDH1A1
SCHEMBL3616171 0.74 HDAC1 (0.50) SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784628-A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME Vertex Pharmaceuticals Incorporated (US) 1997-07-23 — — EP disclosed
WO-1995035308-A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME VERTEX PHARMACEUTICALS INCORPORATED (US) 1995-12-28 — — WO disclosed
Send feedback